Pulmotherapeutics
Tyler, US · Founded 2024 · Delaware corporation
Founders & leadership
NK
Nagarjun Konduru VenkataExecutive
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2025
▶$500KraisedApr 2025 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nagarjun Konduru VenkataExecutive Officer, Director
- Amount sold
- $500K
- Minimum investment
- $10K
- Sales commissions
- $25K
- Finders' fees
- $25K
- Proceeds to insiders
- $250K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pulmotherapeutics raised?
- Pulmotherapeutics has disclosed $500K raised across 1 round.
- Where is Pulmotherapeutics headquartered?
- Pulmotherapeutics is headquartered in Tyler, US.